Precision Biosciences (DTIL) EBIT Margin (2018 - 2026)
Precision Biosciences' EBIT Margin was -83.73% in fiscal Q1 2026 (quarter ended Mar 31, 2026), up 76164.54 percentage points from -76248.28% a year earlier but down 120.30 percentage points from the prior quarter.
Powered by 
Analysis
Precision Biosciences (DTIL) EBIT Margin (2018 - 2026) Analysis & Trends
For FY2025 (ended Dec 31, 2025), EBIT Margin at Precision Biosciences came in at -152.19%, down 114.11 percentage points from FY2024.
- EBIT Margin shows a five-year change of +300.05 percentage points (FY2020 to FY2025).
- In earlier fiscal years, EBIT Margin was -38.08% in FY2024 (+51.67 pp), -89.76% in FY2023 (+158.50 pp), -248.26% in FY2022 (-214.18 pp) and -34.08% in FY2021 (+418.16 pp).
- Quarterly EBIT Margin has moved between -158976.92% (fiscal Q3 2025) and 48.39% (fiscal Q2 2024) over five years.
- Compared with a year earlier, EBIT Margin was higher in three of the last eight quarters, with an average year-over-year change of -35027.19 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was fiscal Q1 2026 (a gain of 76164.54 percentage points); the worst was fiscal Q3 2025 (a drop of 155283.35 percentage points).
- Per Business Quant data, DTIL's EBIT Margin in the three fiscal quarters before Q1 2026 was 36.57% (Q4 2025), -158976.92% (Q3 2025) and -121538.89% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Precision Biosciences | 165.47 Mn | -183.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -83.73% |
| Dec 31, 2025 | 36.57% |
| Sep 30, 2025 | -158,976.92% |
| Jun 30, 2025 | -121,538.89% |
| Mar 31, 2025 | -76,248.28% |
| Dec 31, 2024 | -3,894.36% |
| Sep 30, 2024 | -3,693.58% |
| Jun 30, 2024 | 48.39% |
| Mar 31, 2024 | -23.81% |
| Dec 31, 2023 | -211.57% |
| Sep 30, 2023 | -94.23% |
| Jun 30, 2023 | -15.81% |
| Mar 31, 2023 | -152.10% |
| Dec 31, 2022 | -114.26% |
| Sep 30, 2022 | -199.32% |
| Jun 30, 2022 | -773.66% |
| Mar 31, 2022 | -824.09% |
| Dec 31, 2021 | -484.68% |
| Sep 30, 2021 | -48.02% |
| Jun 30, 2021 | 31.44% |
API Access
Precision Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();